HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reply: 'Comments on Stromal disrupting effects of nab-paclitaxel in pancreatic cancer'.

AuthorsR Alvarez, M Musteanu, E Garcia-Garcia, P P Lopez-Casas, D Megias, C Guerra, M Muñoz, Y Quijano, A Cubillo, J Rodriguez-Pascual, C Plaza, E de Vicente, S Prados, S Tabernero, M Barbacid, F Lopez-Rios, M Hidalgo
JournalBritish journal of cancer (Br J Cancer) Vol. 111 Issue 8 Pg. 1677-8 (Oct 14 2014) ISSN: 1532-1827 [Electronic] England
PMID24642623 (Publication Type: Letter, Research Support, Non-U.S. Gov't, Comment)
Topics
  • Adenocarcinoma (drug therapy)
  • Animals
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Female
  • Fibroblasts (pathology)
  • Humans
  • Male
  • Pancreatic Neoplasms (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: